Related Experiment Video
Updated: Jun 5, 2026
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice
Xin Mu1, Guo-Rong He, Xia Yuan
1Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1, Xian Nong Tan Street, Beijing 100050, China.
Abstract:
Many studies of Parkinson's disease suggest that oxidative stress is involved in the neurodegenerative process. Baicalein has been shown to have antioxidant effects. The present study examines the effect of baicalein on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice. MPTP treatment impaired spontaneous motor activity and rotarod performance, but baicalein improved this deficit. Moreover, baicalein at 280 and 560 mg/kg exhibited a protective effect against the MPTP-induced decrease in tyrosine hydroxylase (TH)-positive fibers in the substantia nigra, demonstrated by the immunohistological, morphological and behavioral outcomes. MPTP treatment also decreased dopamine levels in the striatum. However, treatment with baicalein attenuated these decreases in dopamine levels by changing dopamine catabolism and inhibiting dopamine turnover. The neuroprotective effect of baicalein on dopaminergic neurons may partly be due to its antioxidant properties. Therefore, we speculate that baicalein might be a promising candidate for prevention or treatment of oxidative stress-related neurodegenerative disorders such as Parkinson's disease.
Insights
Baicalein, an antioxidant, shows promise in protecting against Parkinson's disease neurodegeneration. This study found baicalein improved motor function and protected dopamine neurons in mice exposed to MPTP, suggesting its therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Oxidative stress is implicated in Parkinson's disease pathogenesis.
- Baicalein possesses known antioxidant properties.
Purpose of the Study:
- To investigate the neuroprotective effects of baicalein against MPTP-induced neurotoxicity in a mouse model.
- To evaluate baicalein's impact on motor function, dopaminergic neuron survival, and dopamine levels.
Main Methods:
- C57BL/6 mice were treated with MPTP to induce Parkinson's-like pathology.
- Baicalein was administered at doses of 280 and 560 mg/kg.
- Neuroprotection was assessed via behavioral tests (motor activity, rotarod), immunohistochemistry for tyrosine hydroxylase (TH), and striatal dopamine level measurements.
Main Results:
- MPTP treatment significantly impaired motor activity and rotarod performance.
- Baicalein administration dose-dependently improved motor deficits.
- Baicalein protected tyrosine hydroxylase (TH)-positive dopaminergic neurons in the substantia nigra and attenuated MPTP-induced dopamine depletion in the striatum.
Conclusions:
- Baicalein demonstrates significant neuroprotective effects against MPTP-induced neurotoxicity in mice.
- The antioxidant properties of baicalein likely contribute to its protective mechanisms.
- Baicalein is a potential therapeutic candidate for Parkinson's disease and other oxidative stress-related neurodegenerative disorders.
